Heron Therapeutics Inc vs Prudential Financial Inc — how do they compare? Heron Therapeutics Inc trades at $0.48 (market cap $91.46M), while Prudential Financial Inc trades at $117.2 (market cap $40.97B). The key difference: Prudential Financial Inc is far larger — about 448× Heron Therapeutics Inc's market cap, and Prudential Financial Inc pays a 4.75% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | PRU | |
|---|---|---|
Market Cap | $91.46M | $40.97B |
Sector | Health | Financials |
52-Week High | $1.96 | $119.07 |
52-Week Low | $0.39 | $92.00 |
Enterprise Value | $189.36M | $68.03B |
Dividend Yield | — | 4.75% |
Trailing returns across standard periods
Latest headlines on both assets
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →